Literature DB >> 22550063

Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice.

Gary K Yang1, Bertil B Fredholm, Timothy J Kieffer, Yin Nam Kwok.   

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by the inability of the pancreatic β-cells to secrete enough insulin to meet the demands of the body. Therefore, research of potential therapeutic approaches to treat T2DM has focused on increasing insulin output from β-cells or improving systemic sensitivity to circulating insulin. In this study, we examined the role of the A(1) receptor in glucose homeostasis with the use of A(1) receptor knockout mice (A(1)R(-/-)). A(1)R(-/-) mice exhibited superior glucose tolerance compared with wild-type controls. However, glucose-stimulated insulin release, insulin sensitivity, weight gain, and food intake were comparable between the two genotypes. Following a glucose challenge, plasma glucagon levels in wild-type controls decreased, but this was not observed in A(1)R(-/-) mice. In addition, pancreas perfusion with oscillatory glucose levels of 10-min intervals produced a regular pattern of pulsatile insulin release with a 10-min cycling period in wild-type controls and 5 min in A(1)R(-/-) mice. When the mice were fed a high-fat diet (HFD), both genotypes exhibited impaired glucose tolerance and insulin resistance. Increased insulin release was observed in HFD-fed mice in both genotypes, but increased glucagon release was observed only in HFD-fed A(1)R(-/-) mice. In addition, the regular patterns of insulin release following oscillatory glucose perfusion were abolished in HFD-fed mice in both genotypes. In conclusion, A(1) receptors in the pancreas are involved in regulating the temporal patterns of insulin release, which could have implications in the development of glucose intolerance seen in T2DM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550063     DOI: 10.1152/ajpendo.00050.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  9 in total

Review 1.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

2.  Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses.

Authors:  Ting Yang; Xiang Gao; Monica Sandberg; Christa Zollbrecht; Xing-Mei Zhang; Michael Hezel; Ming Liu; Maria Peleli; En-Yin Lai; Robert A Harris; A Erik G Persson; Bertil B Fredholm; Leif Jansson; Mattias Carlström
Journal:  Diabetologia       Date:  2015-04-03       Impact factor: 10.122

Review 3.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

Review 4.  Modulation of pancreatic exocrine and endocrine secretion.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

5.  Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.

Authors:  Milka Koupenova; Katya Ravid
Journal:  J Cell Physiol       Date:  2013-03-04       Impact factor: 6.384

6.  Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes.

Authors:  Linda Yip; Cariel Taylor; Chan C Whiting; C Garrison Fathman
Journal:  Diabetes       Date:  2013-12       Impact factor: 9.461

7.  Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice.

Authors:  Keiji Shimada; Keizo Kanasaki; Makoto Kato; Yoshio Ogura; Yuta Takagaki; Itaru Monno; Taro Hirai; Munehiro Kitada; Daisuke Koya
Journal:  J Diabetes Investig       Date:  2022-03-09       Impact factor: 3.681

Review 8.  The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes.

Authors:  Joanne S J Chia; Jennifer L McRae; Peter J Cowan; Karen M Dwyer
Journal:  J Biomed Biotechnol       Date:  2012-10-14

Review 9.  New Molecular Insights of Insulin in Diabetic Cardiomyopathy.

Authors:  Francisco Westermeier; Jaime A Riquelme; Mario Pavez; Valeria Garrido; Ariel Díaz; Hugo E Verdejo; Pablo F Castro; Lorena García; Sergio Lavandero
Journal:  Front Physiol       Date:  2016-04-12       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.